PortfoliosLab logoPortfoliosLab logo
RXD vs. YSPY
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

RXD vs. YSPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares UltraShort Health Care (RXD) and GraniteShares YieldBOOST SPY ETF (YSPY). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

RXD vs. YSPY - Yearly Performance Comparison


2026 (YTD)2025
RXD
ProShares UltraShort Health Care
9.76%-10.42%
YSPY
GraniteShares YieldBOOST SPY ETF
-6.65%9.17%

Returns By Period

In the year-to-date period, RXD achieves a 9.76% return, which is significantly higher than YSPY's -6.65% return.


RXD

1D
-2.00%
1M
14.23%
YTD
9.76%
6M
-5.46%
1Y
-7.76%
3Y*
-5.35%
5Y*
-8.88%
10Y*
-19.74%

YSPY

1D
0.52%
1M
-11.39%
YTD
-6.65%
6M
-5.59%
1Y
13.22%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


RXD vs. YSPY - Expense Ratio Comparison

RXD has a 0.95% expense ratio, which is lower than YSPY's 1.07% expense ratio.


Return for Risk

RXD vs. YSPY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RXD
RXD Risk / Return Rank: 99
Overall Rank
RXD Sharpe Ratio Rank: 88
Sharpe Ratio Rank
RXD Sortino Ratio Rank: 88
Sortino Ratio Rank
RXD Omega Ratio Rank: 88
Omega Ratio Rank
RXD Calmar Ratio Rank: 1010
Calmar Ratio Rank
RXD Martin Ratio Rank: 1010
Martin Ratio Rank

YSPY
YSPY Risk / Return Rank: 3333
Overall Rank
YSPY Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
YSPY Sortino Ratio Rank: 2828
Sortino Ratio Rank
YSPY Omega Ratio Rank: 3333
Omega Ratio Rank
YSPY Calmar Ratio Rank: 3535
Calmar Ratio Rank
YSPY Martin Ratio Rank: 3939
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RXD vs. YSPY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Health Care (RXD) and GraniteShares YieldBOOST SPY ETF (YSPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RXDYSPYDifference

Sharpe ratio

Return per unit of total volatility

-0.22

0.61

-0.83

Sortino ratio

Return per unit of downside risk

-0.08

0.87

-0.95

Omega ratio

Gain probability vs. loss probability

0.99

1.14

-0.15

Calmar ratio

Return relative to maximum drawdown

-0.12

0.94

-1.05

Martin ratio

Return relative to average drawdown

-0.20

3.80

-3.99

RXD vs. YSPY - Sharpe Ratio Comparison

The current RXD Sharpe Ratio is -0.22, which is lower than the YSPY Sharpe Ratio of 0.61. The chart below compares the historical Sharpe Ratios of RXD and YSPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


RXDYSPYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.22

0.61

-0.83

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.30

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.60

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.65

0.08

-0.73

Correlation

The correlation between RXD and YSPY is -0.45. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.


Dividends

RXD vs. YSPY - Dividend Comparison

RXD's dividend yield for the trailing twelve months is around 2.55%, less than YSPY's 63.03% yield.


TTM20252024202320222021202020192018
RXD
ProShares UltraShort Health Care
2.55%3.29%4.36%3.17%0.67%0.00%0.17%1.73%0.22%
YSPY
GraniteShares YieldBOOST SPY ETF
63.03%45.57%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

RXD vs. YSPY - Drawdown Comparison

The maximum RXD drawdown since its inception was -99.65%, which is greater than YSPY's maximum drawdown of -18.74%. Use the drawdown chart below to compare losses from any high point for RXD and YSPY.


Loading graphics...

Drawdown Indicators


RXDYSPYDifference

Max Drawdown

Largest peak-to-trough decline

-99.65%

-18.74%

-80.91%

Max Drawdown (1Y)

Largest decline over 1 year

-34.76%

-14.60%

-20.16%

Max Drawdown (5Y)

Largest decline over 5 years

-46.27%

Max Drawdown (10Y)

Largest decline over 10 years

-90.64%

Current Drawdown

Current decline from peak

-99.59%

-11.93%

-87.66%

Average Drawdown

Average peak-to-trough decline

-81.72%

-5.01%

-76.71%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.54%

3.60%

+16.94%

Volatility

RXD vs. YSPY - Volatility Comparison

ProShares UltraShort Health Care (RXD) has a higher volatility of 9.50% compared to GraniteShares YieldBOOST SPY ETF (YSPY) at 7.90%. This indicates that RXD's price experiences larger fluctuations and is considered to be riskier than YSPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


RXDYSPYDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.50%

7.90%

+1.60%

Volatility (6M)

Calculated over the trailing 6-month period

20.72%

16.86%

+3.86%

Volatility (1Y)

Calculated over the trailing 1-year period

35.41%

21.81%

+13.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

29.44%

22.59%

+6.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.84%

22.59%

+10.25%